Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Viral Hepatitis Market from 2024 to 2033?

The viral hepatitis market size has grown steadily, projected to rise from $15.48 billion in 2023 to $16.21 billion in 2024, at a CAGR of 4.7%. Growth is attributed to vaccine development, blood screening programs, antiviral drugs, and global health initiatives.

The viral hepatitis market is expected to grow steadily, reaching $19.01 billion by 2028 at a CAGR of 4.1%. The growth is attributed to increased access to treatment, public health legislation, combination therapies, and health equity initiatives. Key trends include personalized treatment plans, digital health tools, AI in disease monitoring, and hepatitis C micro-elimination.

Claim Your Free Sample of the Global Viral Hepatitis Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13028&type=smp

The rise in hepatitis cases is anticipated to propel the viral hepatitis market. Hepatitis viruses, particularly A, B, C, D, and E, cause liver inflammation and damage. The CDC reported in August 2023 that there were about 9,952 hepatitis A cases and 4,798 acute hepatitis C cases in the U.S. in 2020, with 107,300 new chronic hepatitis C cases reported from 41 states. This increase in hepatitis cases is driving the viral hepatitis market.

1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Treatment: Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Companies in the viral hepatitis market are advancing new drug development to maintain their market leadership. In November 2022, Gilead Sciences Inc. announced the FDA approval of Vemlidy (tenofovir alafenamide) 25 mg tablets for the treatment of chronic hepatitis B virus (HBV) infection in children aged 12 and older. This approval was based on results from a 24-week Phase 2 clinical trial supporting its use in pediatric patients with compensated liver disease.

Order Now for Fast Delivery of Your Viral Hepatitis Market Report!

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Asia-Pacific was the largest region in the gestational trophoblastic disease market in 2022, and is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational trophoblastic disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Viral Hepatitis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the viral hepatitis market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Viral Hepatitis Market Include

1. Viral Hepatitis Market Executive Summary

2. Viral Hepatitis Market Segments

3. Viral Hepatitis Market Size And Template Market Growth Rate

4. Key Viral Hepatitis Market Trends

5. Major Viral Hepatitis Market Drivers

……

25. Key Mergers And Acquisitions In The Viral Hepatitis Market

26. Top Viral Hepatitis Companies

27. Viral Hepatitis Market Opportunities And Strategies

28. Viral Hepatitis Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: